Summary
Evidence suggesting the involvement of specific soma-dendritic, presynaptic, and postsynaptic receptors in central noradrenergic and dopaminergic transmission is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergström, S., Farnebo, L.O., Fuxe, K.: Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Europ. J. Pharmacol. 21, 362–368 (1973)
Cedarbaum, J.M., Aghajanian, G.K.: Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res. 112, 413–419 (1976)
Daly, J.W.: The nature of receptors regulating the formation of cyclic AMP in brain tissue. Life Sci. 18, 1349–1358 (1976)
Farnebo, L.O., Hamberger, B.: Drug-induced changes in the release of3H-monoamines from field stimulated rat brain slices. Acta physiol. scand. Suppl. 371, 35–44 (1971)
Graefe, K.H., Stefano, FJ.E., Langer, S.Z.: Preferential metabolism of (−)-3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem. Pharmacol. 22, 1147–1160 (1973)
Korf, J., Bunney, B.S., Aghajanian, G.K.: Noradrenergic neurons: morphine inhibition of spontaneous activity. Europ. J. Pharmacol. 25, 165–169 (1974)
Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Ergebn. Physiol. (Rev. Physiol.), in press (1976)
Starke, K., Montel, H.: Interaction between indomethacin, oxymetazoline and phentolamine on the release of (3H) noradrenaline from brain slices. J. Pharm. Pharmacol. 25, 758–759 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Starke, K., Taube, H.D. & Borowski, E. Pre- and postsynaptic receptors in catecholaminergic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 297 (Suppl 1), S43–S44 (1977). https://doi.org/10.1007/BF00587772
Issue Date:
DOI: https://doi.org/10.1007/BF00587772